Pfizer to pay $2.3 billion in Medicare/Medicaid Fraud
This past February, I wrote about the spread of physician learning concerning harmful side-effects of Cox-2 inhibitors, including Bextra. Today, The New York Times reports that Pfizer has agreed to pay a $2.3 billion settlement with CMS over the company’s illegal promotion of its now-withdrawn painkiller, Bextra. “Marketing fraud cases against pharmaceutical companies have become…